129 related articles for article (PubMed ID: 38006944)
1. Purification and Activity Evaluation of a Novel Thrombopoietin Mimetic Peptide.
Liang Y; Li Y; Ma R; Duan C
J Pharm Sci; 2024 Feb; 113(2):359-365. PubMed ID: 38006944
[TBL] [Abstract][Full Text] [Related]
2. Safety, tolerance, pharmacokinetic and pharmacodynamic properties of thrombopoietin mimetic peptide for injection in Chinese healthy volunteers: a randomized, placebo-controlled, double-blind study.
Sheng XY; Liu ZY; Zhao J; Song L; Zhao WM; Zhao X; Cui YM
Platelets; 2022 Nov; 33(8):1185-1191. PubMed ID: 35549802
[TBL] [Abstract][Full Text] [Related]
3. Expression and bioactivity of recombinant human serum albumin and dTMP fusion proteins in CHO cells.
Ru Y; Zhi D; Guo D; Wang Y; Li Y; Wang M; Wei S; Wang H; Wang N; Che J; Li H
Appl Microbiol Biotechnol; 2016 Sep; 100(17):7565-75. PubMed ID: 27115755
[TBL] [Abstract][Full Text] [Related]
4. Avatrombopag and lusutrombopag for thrombocytopenia in people with chronic liver disease needing an elective procedure: a systematic review and cost-effectiveness analysis.
Armstrong N; Büyükkaramikli N; Penton H; Riemsma R; Wetzelaer P; Huertas Carrera V; Swift S; Drachen T; Raatz H; Ryder S; Shah D; Buksnys T; Worthy G; Duffy S; Al M; Kleijnen J
Health Technol Assess; 2020 Oct; 24(51):1-220. PubMed ID: 33108266
[TBL] [Abstract][Full Text] [Related]
5. Developmental differences between newborn and adult mice in response to romiplostim.
Sparger KA; Ramsey H; Lorenz V; Liu ZJ; Feldman HA; Li N; Laforest T; Sola-Visner MC
Platelets; 2018 Jun; 29(4):365-372. PubMed ID: 28548028
[TBL] [Abstract][Full Text] [Related]
6. The pharmacokinetics and pharmacodynamics of GW395058, a peptide agonist of the thrombopoietin receptor, in the dog, a large-animal model of chemotherapy-induced thrombocytopenia.
Case BC; Hauck ML; Yeager RL; Simkins AH; de Serres M; Schmith VD; Dillberger JE; Page RL
Stem Cells; 2000; 18(5):360-5. PubMed ID: 11007920
[TBL] [Abstract][Full Text] [Related]
7. [Expression of TPO mimetic peptide chimeric proteins with human IgG1 Fc fragments and their biological characters].
Li YX; Li C; Tao KH; Jia XH; Cheng DS; Huang PT
Sheng Wu Gong Cheng Xue Bao; 2002 Jul; 18(4):424-30. PubMed ID: 12385237
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic and pharmacodynamic modeling of pegylated thrombopoietin mimetic peptide (PEG-TPOm) after single intravenous dose administration in healthy subjects.
Samtani MN; Perez-Ruixo JJ; Brown KH; Cerneus D; Molloy CJ
J Clin Pharmacol; 2009 Mar; 49(3):336-50. PubMed ID: 19246731
[TBL] [Abstract][Full Text] [Related]
9. Pharmacodynamics and pharmacokinetics of the novel thrombopoietin mimetic peptide RWJ-800088 in humans.
Liem-Moolenaar M; Cerneus D; Molloy CJ; End D; Brown KH; de Kam ML; Cohen AF; van Hensbergen Y; Burggraaf J
Clin Pharmacol Ther; 2008 Oct; 84(4):481-7. PubMed ID: 19238653
[TBL] [Abstract][Full Text] [Related]
10. Rational and efficient preparation of a chimeric protein containing a tandem dimer of thrombopoietin mimetic peptide fused to human growth hormone in Escherichia coli.
Wang S; Shen M; Xu Y; Chen F; Chen M; Chen S; Wang A; Zhang Z; Ran X; Cheng T; Su Y; Wang J
Appl Microbiol Biotechnol; 2013 Apr; 97(7):2885-94. PubMed ID: 23149755
[TBL] [Abstract][Full Text] [Related]
11. Thrombopoietin mimetics for patients with myelodysplastic syndromes.
Dodillet H; Kreuzer KA; Monsef I; Skoetz N
Cochrane Database Syst Rev; 2017 Sep; 9(9):CD009883. PubMed ID: 28962071
[TBL] [Abstract][Full Text] [Related]
12. Thrombopoietin mimetic agents in the management of immune thrombocytopenic purpura.
Newland A
Semin Hematol; 2007 Oct; 44(4 Suppl 5):S35-45. PubMed ID: 18096471
[TBL] [Abstract][Full Text] [Related]
13. Review article: thrombocytopenia in chronic liver disease and pharmacologic treatment options.
Giannini EG
Aliment Pharmacol Ther; 2006 Apr; 23(8):1055-65. PubMed ID: 16611265
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of recombinant human thrombopoietin in the treatment of chemotherapy-induced thrombocytopenia in lung cancer patients].
Xu YH; Chen ZW; Ye XY; Lu S
Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):716-9. PubMed ID: 19173920
[TBL] [Abstract][Full Text] [Related]
15. Recombinant human thrombopoietin in critically ill patients with sepsis-associated thrombocytopenia: A clinical study.
Liu Y; Jin G; Sun J; Wang X; Guo L
Int J Infect Dis; 2020 Sep; 98():144-149. PubMed ID: 32561426
[TBL] [Abstract][Full Text] [Related]
16. Improving pharmacological activities of thrombopoietin mimetic peptide by genetic fusion to albumin-binding domain.
Li D; Gao G; Zhu B; Ying J
Biotechnol Lett; 2023 Apr; 45(4):439-448. PubMed ID: 36879168
[TBL] [Abstract][Full Text] [Related]
17. [The clinical study of recombinant human thrombopoietin in the treatment of chemotherapy-induced severe thrombocytopenia].
Bai CM; Zou XY; Zhao YQ; Han SM; Shan YD;
Zhonghua Yi Xue Za Zhi; 2004 Mar; 84(5):397-400. PubMed ID: 15061993
[TBL] [Abstract][Full Text] [Related]
18. Insulin-like growth factor-1 fused with thrombopoietin mimetic peptide effectively increase platelets count in vivo.
Zhang HT; Li ZW; Guo CH; Zhang XQ; Chen YJ; Li HC
Saudi Med J; 2011 Mar; 32(3):254-9. PubMed ID: 21384060
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and hematological effects of the PEGylated thrombopoietin peptide mimetic GW395058 in rats and monkeys after intravenous or subcutaneous administration.
de Serres M; Yeager RL; Dillberger JE; Lalonde G; Gardner GH; Rubens CA; Simkins AH; Sailstad JM; McNulty MJ; Woolley JL
Stem Cells; 1999; 17(6):316-26. PubMed ID: 10606160
[TBL] [Abstract][Full Text] [Related]
20. Peptide agonists of the thrombopoietin receptor.
Dower WJ; Cwirla SE; Balasubramanian P; Schatz PJ; Baccanari DP; Barrett RW
Stem Cells; 1998; 16 Suppl 2():21-9. PubMed ID: 11012174
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
